Howe & Rusling’s Codexis CDXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,000
Closed -$30K 439
2022
Q3
$30K Hold
5,000
﹤0.01% 374
2022
Q2
$52K Hold
5,000
0.01% 304
2022
Q1
$103K Hold
5,000
0.01% 252
2021
Q4
$156K Hold
5,000
0.02% 216
2021
Q3
$116K Hold
5,000
0.01% 236
2021
Q2
$113K Hold
5,000
0.01% 230
2021
Q1
$114K Hold
5,000
0.02% 222
2020
Q4
$109K Hold
5,000
0.02% 218
2020
Q3
$59K Hold
5,000
0.01% 253
2020
Q2
$57K Hold
5,000
0.01% 238
2020
Q1
$56K Sell
5,000
-55
-1% -$769 0.01% 243
2019
Q4
$81K Hold
5,055
0.01% 246
2019
Q3
$69K Hold
5,055
0.01% 265
2019
Q2
$93K Hold
5,055
0.02% 251
2019
Q1
$104K Buy
5,055
+55
+1% +$1.07K 0.02% 232
2018
Q4
$84K Hold
5,000
0.02% 218
2018
Q3
$86K Hold
5,000
0.01% 212
2018
Q2
$72K Hold
5,000
0.01% 223
2018
Q1
$55K Hold
5,000
0.01% 265
2017
Q4
$42K Hold
5,000
0.01% 315
2017
Q3
$33K Hold
5,000
0.01% 339
2017
Q2
$27K Buy
+5,000
New +$23K 0.01% 336

Other funds holding CDXS

Howe & Rusling's CDXS Position: Q4 2022 in Review

Howe & Rusling sold out of Codexis (CDXS) in Q4 2022, closing a stake of 5,000 shares — an estimated $30K sold.

Howe & Rusling first reported a position in CDXS in Q2 2017 and held it in 22 quarters. The position peaked at $156K in Q4 2021. 166 funds tracked by Wall St. Rank hold CDXS as of Q4 2022.

  • Howe & Rusling reported no remaining Codexis position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 5,000 Codexis shares in Q4 2022, an estimated $30K.
  • Howe & Rusling first reported a position in Codexis in Q2 2017 and held it in 22 quarters.
  • Howe & Rusling's Codexis position peaked at $156K in Q4 2021.
  • 166 funds tracked by Wall St. Rank held Codexis as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.